Overview

Clinical Study to Evaluate the Efficacy of Prasterone Treatment for Atrophy Vulvovaginal in Postmenopausal Women With Vulvar / Vestibular Pain

Status:
Recruiting

Trial end date:
2021-06-30

Target enrollment:

Participant gender:

Summary

A prospective, open, randomized and controlled clinical intervention study in women over 45 years of age with a diagnosis of vulvovaginal atrophy (dryness and / or dyspareunia, etc.) and vulvar and / or vestibular pain. The efficacy of Prasterone treatment is evaluated in those patients willing to undergo the treatment compared to the control group.

Phase:

Phase 3

Details

Lead Sponsor:

Dr. Santiago Palacios

Treatments:

Dehydroepiandrosterone